Table 2.
Disease characteristics and functional status of patients
| Parameters | n=274 ave±SD, n (%) |
|---|---|
| Disease time (year) | 13.31±9.32 |
| Diagnosis time (year) | 5.87±2.41 |
| Morning stiffness (min) | 47.84±21.43 |
| DAS 28 score | 4.42±1.18 |
| Number of tender joints | 8.64±6.18 |
| Number of swollen joints | 2.24±1.25 |
| ESR level (mm/h) (0–20) | 27.43±18.30 |
| VAS (0–100 mm) | 44.27±24.13 |
| CRP (μg/dL) (0–5) | 13.08±12.61 |
| RF (IU/mL) (0–20) | 98.22±56.64 |
| m-HAQ (0–3) | 1.21±0.68 |
| BDI score (0–63) | 21.06±11.89 |
| BAI score (0–63) | 20.01±11.92 |
| Level of tension (AIMS-2) (0–10) | 5.50±1.74 |
| Mood status (AIMS-2) (0–10) | 5.49±1.58 |
| Satisfaction with health (AIMS-2) (0–10) | 7.32±2.85 |
| General perception of health (AIMS-2) (0–10) | 7.29±1.94 |
ave±SD:average±standard deviation; DAS 28: Disease Activity Score 28; ESR: Erythrocyte Sedimentation Rate; VAS: Visual Analog Scale; CRP: C-reactive protein; RF: rheumatoid factor; m-HAQ: Modified Health Assessment Questionnaire; BDI: Beck Depression Inventory; BAI: Beck Anxiety Inventory; AIMS-2: Arthritis Impact Measurement Scale-2